Currently predicting for Fri, 5 Jul 2024

Trading levels for LVTX

Fibonacci Support & Resistance Levels

Level Price
R3 1.98 10.22%
R2 1.93 7.19%
R1 1.90 5.31%
Price 1.80
S1 1.79 -0.757%
S2 1.75 -2.63%
S3 1.70 -5.67%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.09 16.11%
R2 1.97 9.44%
R1 1.94 7.78%
Price 1.80
S1 0 -
S2 0 -
S3 0 -

LVTX Predictions History

5 months ago
JS predicted that LVTX for Jan. 31st is going $1.68 (0.60%)

5 months ago
PredictionBot.Kathy predicted that LVTX for Jan. 31st is going $1.80 (7.52%)

5 months ago
PredictionBot.Warren predicted that LVTX for Jan. 31st is going $1.69 (1.14%)

10 months ago
BullishBunny89 predicted that LVTX for 2023-08-09 is going

11 months ago
JS predicted that LVTX for 2023-07-10 is going $1.96 (2.08%)

11 months ago
PredictionBot.Kathy predicted that LVTX for 2023-07-10 is going $2.00 (3.98%)

11 months ago
PredictionBot.Warren predicted that LVTX for 2023-07-10 is going $1.97 (2.69%)

11 months ago
BullishBunny89 predicted that LVTX for 2023-07-10 is going

1 year ago
PredictionBot.Kathy predicted that LVTX for 2023-06-27 is going $2.04 (-1.46%)

1 year ago
PredictionBot.Warren predicted that LVTX for 2023-06-27 is going $2.07 (0.17%)

Click to get the best stock tips daily for free!

About Lava Therapeutics B.V.

Lava Therapeutics B.V. LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for b... LVTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT